Search

3 results

Diagnostic testing and antibiotic utilization among inpatients evaluated for coronavirus disease 2019 (COVID-19) pneumonia
Megan R. Wimmer, Meggie Griffin, Alex Peterson-Weber, Lucas T. Schulz, Ashlee G. Hamel, Rebecca J. Schwei, Karen Fong, Donna R. Burgess, Meghan Brett, Cory M. Hale, Marisa Holubar, Rupali Jain, Rachel Larry, Emily S. Spivak, Helen Newland, Jessica Njoku, Michael Postelnick, Carla Walraven, Michael S. Pulia
Journal:

Infection Control & Hospital Epidemiology / Volume 45 / Issue 5 / May 2024

Published online by Cambridge University Press:

28 December 2023, pp. 667-669

Print publication:

May 2024
- Article
- - You have access
- PDF
- HTML
- Export citation
We evaluated diagnostic test and antibiotic utilization among 252 patients from 11 US hospitals who were evaluated for coronavirus disease 2019 (COVID-19) pneumonia during the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) omicron variant pandemic wave. In our cohort, antibiotic use remained high (62%) among SARS-CoV-2–positive patients and even higher among those who underwent procalcitonin testing (68%).

The impact of coronavirus disease 2019 (COVID-19) on the antimicrobial stewardship pharmacist workforce: A multicenter survey
Megan R. Wimmer, Lucas T. Schulz, Ashlee G. Hamel, Rebecca J. Schwei, Karen Fong, Donna R. Burgess, Meghan Brett, Cory M. Hale, Marisa Holubar, Rupali Jain, Rachel Larry, Emily S. Spivak, Helen Newland, Jessica Njoku, Michael Postelnick, Carla Walraven, Michael S. Pulia
Journal:

Antimicrobial Stewardship & Healthcare Epidemiology / Volume 2 / Issue 1 / 2022

Published online by Cambridge University Press:

07 April 2022, e56
- Article
- - You have access
  - Open access
- PDF
- HTML
- Export citation
Objective:
The coronavirus disease 2019 (COVID-19) pandemic has required healthcare systems and hospitals to rapidly modify standard practice, including antimicrobial stewardship services. Our study examines the impact of COVID-19 on the antimicrobial stewardship pharmacist.
Design:
A survey was distributed nationally to all healthcare improvement company members.
Participants:
Pharmacist participants were mostly leaders of antimicrobial stewardship programs distributed evenly across the United States and representing urban, suburban, and rural health-system practice sites.
Results:
Participants reported relative increases in time spent completing tasks related to medication access and preauthorization (300%; P = .018) and administrative meeting time (34%; P = .067) during the COVID-19 pandemic compared to before the pandemic. Time spent rounding, making interventions, performing pharmacokinetic services, and medication reconciliation decreased.
Conclusion:
A shift away from clinical activities may negatively affect the utilization of antimicrobials.

Lack of Benefit With Combination Therapy for Clostridium difficile Infection
Jessica C. Njoku, Trevor C. Van Schooneveld, Mark E. Rupp, Keith M. Olsen, Fang Qiu, Jane L. Meza, Elizabeth D. Hermsen
Journal:

Infection Control & Hospital Epidemiology / Volume 38 / Issue 5 / May 2017

Published online by Cambridge University Press:

06 February 2017, pp. 602-605

Print publication:

May 2017
- Article
- - Get access
    
    Check if you have access via personal or institutional login
    
    Log in Register
- Export citation
Limited data exist regarding combination therapy for Clostridium difficile infection (CDI). After adjusting for confounders in a cohort of patients with CDI and≥1 year old, combination therapy was not associated with significant differences in clinical outcomes, but it was associated with prolonged duration of therapy (1.22 days; 95% confidence interval, 1.03–1.44 days; P=.02).
Infect Control Hosp Epidemiol 2017;38:602–605

Search Results

Refine search

Refine search

Actions for selected content:

3 results

Diagnostic testing and antibiotic utilization among inpatients evaluated for coronavirus disease 2019 (COVID-19) pneumonia

The impact of coronavirus disease 2019 (COVID-19) on the antimicrobial stewardship pharmacist workforce: A multicenter survey

Lack of Benefit With Combination Therapy for Clostridium difficile Infection

Search Results

Refine search

Refine search

Actions for selected content:

Save Search

3 results

Diagnostic testing and antibiotic utilization among inpatients evaluated for coronavirus disease 2019 (COVID-19) pneumonia

The impact of coronavirus disease 2019 (COVID-19) on the antimicrobial stewardship pharmacist workforce: A multicenter survey

Lack of Benefit With Combination Therapy for Clostridium difficile Infection